Trajectories of forced vital capacity in patients with systemic sclerosis-associated interstitial lung disease
Abstract We used data from the SENSCIS and SENSCIS-ON trials to assess decline in forced vital capacity (FVC) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD) who received long-term treatment with nintedanib and the effect of switching patients from placebo to ninte...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2025-03-01
|
| Seri Bilgileri: | Arthritis Research & Therapy |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s13075-025-03524-9 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|